D. L. Healy

781 total citations
21 papers, 610 citations indexed

About

D. L. Healy is a scholar working on Reproductive Medicine, Public Health, Environmental and Occupational Health and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, D. L. Healy has authored 21 papers receiving a total of 610 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Reproductive Medicine, 11 papers in Public Health, Environmental and Occupational Health and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in D. L. Healy's work include Reproductive Biology and Fertility (11 papers), Ovarian function and disorders (10 papers) and Growth Hormone and Insulin-like Growth Factors (4 papers). D. L. Healy is often cited by papers focused on Reproductive Biology and Fertility (11 papers), Ovarian function and disorders (10 papers) and Growth Hormone and Insulin-like Growth Factors (4 papers). D. L. Healy collaborates with scholars based in Australia, Switzerland and United Kingdom. D. L. Healy's co-authors include Henry Burger, R. I. McLachlan, Helen Buckler, D.M. Robertson, R. J. Pepperell, Alan S. McNeilly, David M. de Kretser, Vivien MacLachlan, David Robertson and David J. Handelsman and has published in prestigious journals such as The Lancet, The Journal of Clinical Endocrinology & Metabolism and Human Reproduction.

In The Last Decade

D. L. Healy

20 papers receiving 580 citations

Peers

D. L. Healy
L.W. Eddie Australia
P. E. Lebech Denmark
Gary W. DeVane United States
Elizabeth A. Kennard United States
Marita Pall United States
J. Adams United States
L.W. Eddie Australia
D. L. Healy
Citations per year, relative to D. L. Healy D. L. Healy (= 1×) peers L.W. Eddie

Countries citing papers authored by D. L. Healy

Since Specialization
Citations

This map shows the geographic impact of D. L. Healy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. L. Healy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. L. Healy more than expected).

Fields of papers citing papers by D. L. Healy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. L. Healy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. L. Healy. The network helps show where D. L. Healy may publish in the future.

Co-authorship network of co-authors of D. L. Healy

This figure shows the co-authorship network connecting the top 25 collaborators of D. L. Healy. A scholar is included among the top collaborators of D. L. Healy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. L. Healy. D. L. Healy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Healy, D. L.. (2002). Reproductive medicine in the twenty-first century : proceedings of the 17th World Congress on Fertility and Sterility, Melbourne, Australia. 2 indexed citations
2.
Burger, Henry, et al.. (2002). Surgical or medical treatment of polycystic ovary syndrome: a cost–benefit analysis. Gynecological Endocrinology. 16(1). 53–55. 12 indexed citations
3.
Howles, Colin M., Ernest Loumaye, M. Germond, et al.. (1999). Does growth hormone-releasing factor assist follicular development in poor responder patients undergoing ovarian stimulation for in-vitro fertilization?. Human Reproduction. 14(8). 1939–1943. 42 indexed citations
4.
Rombauts, Luk, Richard J. Wicks, P. Jackson, et al.. (1997). R-076. Oocyte maturation and the use of caffeine and nicotine. Human Reproduction. 12(Suppl_2). 269–269. 1 indexed citations
5.
Rombauts, Luk & D. L. Healy. (1995). Inhibins and activins in reproduction. Current Obstetrics and Gynaecology. 5(3). 155–162.
6.
McClure, Neil, et al.. (1994). An immunohistochemical study of the vascularization of the human Graafian follicle. Human Reproduction. 9(8). 1401–1405. 15 indexed citations
7.
Buckler, Helen, D. L. Healy, & Henry Burger. (1993). Does Gonadotropin Suppression Result in Follicular Development in Premature Ovarian Failure?. Gynecological Endocrinology. 7(2). 123–128. 8 indexed citations
8.
Bangah, Mohan, et al.. (1993). Follicle-stimulating hormone induces dose-dependant stimulation of immunoreactive inhibin secretion during the follicular phase of the human menstrual cycle.. The Journal of Clinical Endocrinology & Metabolism. 76(5). 1340–1343. 20 indexed citations
9.
Buckler, Helen, Mohan Bangah, D. L. Healy, & Henry Burger. (1992). Vaginal progesterone administration in physiological doses normalizes raised luteinizing hormone levels in patients with polycystic ovarian syndrome. Gynecological Endocrinology. 6(4). 275–282. 10 indexed citations
10.
Buckler, Helen, D. L. Healy, & Henry Burger. (1989). Purified FSH stimulates production of inhibin by the human ovary. Journal of Endocrinology. 122(1). 279–285. 30 indexed citations
11.
Buckler, Helen, R. I. McLachlan, Vivien MacLachlan, D. L. Healy, & Henry Burger. (1988). Serum Inhibin Levels in Polycystic Ovary Syndrome: Basal Levels and Response to Luteinizing Hormone-Releasing Hormone Agonist and Exogenous Gonadotropin Administration*. The Journal of Clinical Endocrinology & Metabolism. 66(4). 798–803. 54 indexed citations
12.
Robertson, David, C. G. Tsonis, R. I. McLachlan, et al.. (1988). Comparison of Inhibin Immunological andin VitroBiological Activities in Human Serum*. The Journal of Clinical Endocrinology & Metabolism. 67(3). 438–443. 131 indexed citations
13.
Besanko, M, et al.. (1988). A comparison of plasma BIO-LH levels with RIA-LH and IRMA-LH in spontaneous menstrual cycles and in women receiving LHRH agonist treatment for IVF. European Journal of Endocrinology. 117(4_Suppl). S103–S103. 1 indexed citations
14.
Healy, D. L., et al.. (1987). 7Contributions of in vitro fertilization to knowledge of the reproductive endocrinology of the menstrual cycle. Baillière s Clinical Endocrinology and Metabolism. 1(1). 133–152. 7 indexed citations
15.
McLachlan, R. I., et al.. (1986). PLASMA INHIBIN LEVELS DURING GONADOTROPIN-INDUCED OVARIAN HYPERSTIMULATION FOR IVF: A NEW INDEX OF FOLLICULAR FUNCTION?. The Lancet. 327(8492). 1233–1234. 111 indexed citations
16.
Healy, D. L., Michael Quinn, & R. J. Pepperell. (1982). Rotational delivery of the fetus: Kielland's forceps and two other methods compared. BJOG An International Journal of Obstetrics & Gynaecology. 89(7). 501–506. 31 indexed citations
17.
Healy, D. L.. (1982). Design Errors in Kielland's Forceps. Australian and New Zealand Journal of Obstetrics and Gynaecology. 22(1). 31–33. 1 indexed citations
18.
Healy, D. L., Stephen Rattigan, Peter Hartmann, Adrian C. Herington, & Henry Burger. (1980). Prolactin in human milk: correlation with lactose, total protein, and alpha-lactalbumin levels. American Journal of Physiology-Endocrinology and Metabolism. 238(1). E83–E86. 31 indexed citations
19.
Healy, D. L., et al.. (1977). Pituitary Autonomy in Hyperprolactinemic Secondary Amenorrhea: Results of Hypothalamic-Pituitary Testing. The Journal of Clinical Endocrinology & Metabolism. 44(5). 809–819. 34 indexed citations
20.
Pepperell, R. J., Jemma Evans, J. B. Brown, et al.. (1977). A STUDY OF THE EFFECTS OF BROMOCRIPTINE ON SERUM PROLACTIN, FOLLICLE STIMULATING HORMONE AND LUTEINIZING HORMONE AND ON OVARIAN RESPONSIVENESS TO EXOGENOUS GONADOTROPHINS IN ANOVULATORY WOMEN. BJOG An International Journal of Obstetrics & Gynaecology. 84(6). 456–463. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026